Results 281 to 290 of about 757,915 (376)

Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

Exploration, EarlyView.
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu, Junya Feng, Jie Ma, Tixian Xiao, Wei Yuan   +4 more
wiley   +1 more source

The role of PilU in the surface behaviors of Pseudomonas aeruginosa. [PDF]

mLife
Zhang J, Luo Y, Zong Y, Lu S, Shi Y, Jin F, Zhao K.   +6 more
europepmc   +1 more source

Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application

Exploration, EarlyView.
This perspective highlights synthetic biology‐driven antibacterial strategies, focusing on three innovative approaches: engineered bacteriophages for precision bacterial targeting, reprogrammed microbes that detect quorum‐sensing signals or metabolites to release antimicrobials, and engineering mammalian cells that recognize pathogen‐associated ...
Shun Huang, Shuihao Zhao, Haijie Zhao, Mingzhang Wen, Zhong Guo   +4 more
wiley   +1 more source

Antagonistic effect of <i>Pseudomonas aeruginosa</i> on <i>Candida auris</i>. [PDF]

Front Fungal Biol
Macedo ABN, Silva DF, Medeiros AGJ, Freitas GJ, Dos Santos MM, Ishida K, Peres NTA, Santos DA, Rossato L, Goldman GH, Bastos RW.   +10 more
europepmc   +1 more source

Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD‐Bronchiectasis Association: A Prospective Cohort Study

Exploration, EarlyView.
This study aimed to determine how microbiota compositions (via 16S rRNA sequencing) correlate with clinical outcome and metabolome (via liquid chromatography/mass spectrometry) of CBA. Sputum microbiome and metabolome profiles of CBA were well separated from COPD but not bronchiectasis, partly driven by the higher abundance of Proteobacteria in CBA ...
Zhen‐feng He, Xiao‐xian Zhang, Cui‐xia Pan, Xin‐zhu Yi, Yan Huang, Chun‐lan Chen, Shan‐shan Zha, Lai‐jian Cen, Han‐qin Cai, Lei Yang, Jia‐qi Gao, Hui‐min Li, Zhen‐hong Lin, Sheng‐zhu Lin, Zhang Wang, Nan‐shan Zhong, Wei‐jie Guan   +16 more
wiley   +1 more source

Corticosteroids modulate biofilm formation and virulence of <i>Pseudomonas aeruginosa</i>. [PDF]

Biofilm
Jordana-Lluch E, Escobar-Salom M, Torrens G, Barceló IM, Estévez MÁ, González-Alsina A, Iglesias A, Pont-Antona PJ, Macià MD, Albertí S, Williams P, Cosío BG, Juan C, Oliver A.   +13 more
europepmc   +1 more source

Fatty Acids Synthesized from Hexadecane by Pseudomonas aeruginosa

, 1966
Ethel M. Romero, Rodolfo R. Brenner
openalex   +1 more source

A Mini Review: Key Applications and Advances of Photodynamic Inactivation Against Bacteria in the Food Industry

Food Chemistry International, EarlyView.
Photodynamic inactivation (PDI) technology has emerged as a promising non‐thermal inactivation method in food preservation, demonstrating broad‐spectrum antimicrobial activity against planktonic bacteria, and biofilms while offering potential applications in antibacterial packaging.
Huajian Ou, Yixiang Wang, Qiaohui Zeng, Konglong Feng, Jing Jing Wang   +4 more
wiley   +1 more source

Characterization and purification of Pseudomonas aeruginosa phages for the treatment of canine infections. [PDF]

BMC Microbiol
Dalponte A, Filor V, Lübke-Becker A, Fulde M, Alter T, Müsken M, Bäumer W.   +6 more
europepmc   +1 more source

NONMOTILE VARIETIES OF PSEUDOMONAS AERUGINOSA PRODUCING MELANINLIKE PIGMENT

, 1962
Pinghui V. Liu
openalex   +2 more sources